Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Double Blinded Randomized Controlled Trial Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic Use in Patients Under 55yo After Outpatient Arthroscopic Shoulder Surgery

NCT04633837 is registered in ClinicalTrials.gov with Brian Badman as lead sponsor.

NCT NCT04633837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04633837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Double Blinded Randomized Controlled Trial Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic Use in Patients Under 55yo After Outpatient Arthroscopic Shoulder Surgery
Lead sponsor
Brian Badman
Phase
Not applicable
Overall status
Terminated
Start date
December 4, 2020
Completion date
November 7, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroscopic shoulder surgery, pain, postoperative